RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
NCT: NCT03053141 · RECRUITING
Brief Summary
The objective of the RHAPSODY study is to evaluate the performance of new software features in subjects undergoing standard of care catheter-based endocardial mapping for atrial or ventricular tachyarrhythmias using a commercial Rhythmia Mapping System. Results from this study will be used to guide development and refinement of new software features that may be implemented in future commercial software releases.
Frequently Asked Questions
What is RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)?
RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY) is a clinical trial registered under NCT03053141. Current status: RECRUITING.
What is the status of NCT03053141?
The current status of NCT03053141 (RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)) is: RECRUITING.
When did RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY) start?
RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY) started on 2016-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.